Washington 2025-2026 Regular Session Status: Passed House Bipartisan · 7 D · 1 R cosponsors

HB 1076 — Concerning the health technology assessment program.

Last action — Referred to Health Care & Wellness.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has passed the House. Introduced December 16, 2024. It now moves to the second chamber.

Next likely step: consideration and a floor vote in the Senate.

Odds of enactment

Moderate chance

Based on the sponsor, cosponsors, and committee posture, this bill has a moderate chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Advancing 54% · moderate confidence

  • Passed House

    Current position in the legislative process.

  • 8 sponsors

    1 primary, 7 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (7 D · 1 R) — cross-party backing.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Bill Text

What changed in the latest version

15 added · 14 removed

Plain-language change summary

In the latest version of Bill HB 1076, guidelines from the national comprehensive cancer network have been included, adding more credible references for cancer care recommendations. Additionally, the timeframe for posting information on the authority's website has been shortened from 30 days to just 7 days after receipt. These changes aim to ensure that patients receive faster access to updated and comprehensive cancer treatment information, which can enhance their care and decision-making.

→
Previous
Latest
H-1115.1 SUBSTITUTE HOUSE BILL 1076 State of Washington 69th Legislature 2025 Regular Session By House Health Care & Wellness (originally sponsored by Representatives Walen, Barnard, Reed, Rule, Ryu, Parshley, Leavitt, and Obras) READ FIRST TIME 02/04/25.
H-0077.1 HOUSE BILL 1076 State of Washington 69th Legislature 2025 Regular Session By Representatives Walen, Barnard, Reed, Rule, Ryu, Parshley, Leavitt, and Obras Prefiled 12/16/24.
Read first time 01/13/25.
Referred to Committee on Health Care & Wellness.
(a) For which patient access is established or recommended for a patient population under the federal medicare program, including local coverage determinations or national coverage determinations, or in nationally recognized expert treatment guidelines, including guidelines developed by specialty physician organizations or patient advocacy organizations;
(a) For which patient access is established or recommended for a patient population under the federal medicare program, including local coverage determinations or national coverage determinations, or in nationally recognized expert treatment guidelines, including guidelines developed by the national comprehensive cancer network, specialty physician organizations, or patient advocacy organizations;
and (b) For which:
or (b) For which:
1 SHB 1076 (((a))) (i) There are concerns about its safety, efficacy, or cost-effectiveness, especially relative to existing alternatives, or significant variations in its use;
1 HB 1076 (((a))) (i) There are concerns about its safety, efficacy, or cost-effectiveness, especially relative to existing alternatives, or significant variations in its use;
2 SHB 1076 which the evidence is based, and the consistency of the outcome with comparable studies;
2 HB 1076 which the evidence is based, and the consistency of the outcome with comparable studies;
3 SHB 1076 (3) Determinations of the committee under subsection (1) of this section shall be consistent with decisions made under the federal medicare program and in expert treatment guidelines, including those from specialty physician organizations and patient advocacy organizations, unless the committee concludes, based on its review of the systematic assessment, that substantial evidence regarding the safety, efficacy, and cost-effectiveness of the technology supports a contrary determination.
3 HB 1076 (3) Determinations of the committee under subsection (1) of this section shall be consistent with decisions made under the federal medicare program and in expert treatment guidelines, including those from specialty physician organizations and patient advocacy organizations, unless the committee concludes, based on its review of the systematic assessment, that substantial evidence regarding the safety, efficacy, and cost-effectiveness of the technology supports a contrary determination.
(4) The health care authority shall publish receipt of submissions for new technology assessment and rereview assessments on the authority's website within 30 days of receipt.
(4) The health care authority shall publish receipt of submissions for new technology assessment and rereview assessments on the authority's website within seven days of receipt.
4 SHB 1076
4 HB 1076
⬇ Download PDF
View plain text versions (2)

Action History

  1. Referred to Health Care & Wellness.

  2. Rules Committee relieved of further consideration.

  3. By resolution, reintroduced and retained in present status.

  4. Referred to Rules 2 Review.

  5. Minority; do not pass.

  6. Minority; without recommendation.

  7. HCW - Majority; 1st substitute bill be substituted, do pass.

  8. Executive action taken in the House Committee on Health Care & Wellness at 8:00 AM.

  9. Public hearing in the House Committee on Health Care & Wellness at 1:30 PM.

  10. First reading, referred to Health Care & Wellness.

  11. Prefiled for introduction.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 7 co-sponsors · 143 not signed on

Sponsors (1)

Co-sponsors (7)

Not signed on (143)

143 members have not signed on to this bill.

Show all 143 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare technology
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors HB 1076?
HB 1076 is sponsored by Edwin Obras (Democrat), Mari Leavitt (Democrat), Lisa Parshley (Democrat), Cindy Ryu (Democrat), Alicia Rule (Democrat), Julia Reed (Democrat), Stephanie Barnard (Republican), and Amy Walen (Democrat).
What is the current status of HB 1076?
This bill has passed the House. Introduced December 16, 2024. It now moves to the second chamber.
Where can I track HB 1076?
Track HB 1076 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 1076

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 1076

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →